Professor Dr. Michael Macklin

Biography

Michael Macklin is an Assistant Professor at the University of Chicago in the Department of Medicine, specializing in Rheumatology. He provides expert care for patients with systemic sclerosis (scleroderma) and interstitial lung diseases (ILD). He is the director of the multidisciplinary Scleroderma Program at the University of Chicago, which includes specialists from Pulmonary, Cardiology, Gastroenterology, Plastic Surgery, and Dermatology to offer comprehensive care for individuals diagnosed with systemic sclerosis. His clinical research is focused on improving diagnosis and treatment through clinical trials, including cell therapy involving CAR-T cells. Macklin is also a member of the multidisciplinary ILD group, running a combined rheumatology-pulmonary clinic dedicated to patients with ILD due to autoimmune diseases. The ILD Program at the University of Chicago is recognized internationally for its innovative clinical research. Additionally, he has an interest in IgG4 related disease and is a member of the multidisciplinary IgG4 Clinical Consortium, collaborating with specialists in Gastroenterology, Pathology, Nephrology, Ophthalmology, and Neurology. Macklin is also dedicated to medical education and works with learners at various stages of medical training.

Research Interests